Thyrocare's Rahul Guha to Lead API Holdings as CEO While Retaining Current Role
Rahul Guha, current MD and CEO of Thyrocare Technologies, will additionally become MD and CEO of API Holdings from August 27, 2025. He will maintain his position at Thyrocare while taking on new responsibilities at API Holdings. Siddharth Shah, current MD and CEO of API Holdings, will be re-designated as Director and Vice Chairman. This move aims to enhance synergies between Thyrocare and its parent company, API Holdings.
Thyrocare Technologies Ltd., a leading diagnostics and preventive healthcare service provider, has received two significant tax demands totaling ₹133.10 crore. The demands include ₹2.10 crore and ₹131.00 crore. The company's disclosure lacks specific details about the nature of these demands, the tax periods involved, or the grounds for the claims. This substantial tax liability could potentially impact Thyrocare's financial position, cash flow management, and future planning.
Thyrocare Technologies Strengthens Tanzanian Joint Venture with $25,000 Investment
Thyrocare Technologies has invested an additional $25,000 (₹21.98 lakh) in its Tanzanian joint venture, Thyrocare Laboratories (Tanzania) Limited. This investment is part of a larger ₹15 crore plan. The joint venture, operational since April 2024, reported a turnover of ₹0.44 crore for the nine months ended December 31, 2024. With this investment, Thyrocare's stake temporarily exceeds 50%, potentially making the joint venture a subsidiary. The shareholding is expected to revert to 50:50 once partners contribute their equity portion.